“…Cross-sectional design was most commonly used (Table 1) with 8 case-control studies (Table 2), 13 cohort studies (Table 3) and 7 clinical trials (Table 4). The majority of studies were conducted in UK ( n = 8) [1,18,22,23,24,25,26,27], but also in Australia ( n = 5) [28,29,30,31,32], Greece ( n = 5) [13,33,34,35,36], Spain ( n = 4) [37,38,39,40], Italy ( n = 4) [9,41,42,43], Brazil ( n = 3) [44,45,46], Netherlands ( n = 3) [21,47,48], USA ( n = 3) [9,49,50], Canada ( n = 2) [20,51], Finland ( n = 2) [52,53], India ( n = 2) [54,55], Japan ( n = 2) [56,57], Mexico ( n = 2) [19,58] Sweden ( n = 2) [17,59], Taiwan [60,61] ( n = 2), Albania [62], China [63], Colombia [64], Germany [7], Ireland [65], Norway [66], Portugal [67…”